Doctors Pharmacy Testimonials Trials 
Drug & Device Law
JULY 24, 2023
the relationship between [plaintiff] and its pharmacy benefit manager. . . Apparently, massive loss of evidence was merely a “usual and customary service” of pharmacy benefit mangers nationwide. Thus, “[o]ne supposed ‘nightmare’ trial is preferable to many hundreds of shorter ones.” According to Plaintiffs’ expert. . .,
Drug & Device Law
DECEMBER 29, 2023
2023) (remote trial testimony cannot be compelled beyond Rule 45’s 100-mile limit on subpoenas) ( here ); Carson v. They excluded bogus expert testimony under Fed. Further, “adequacy” is an objective standard, that neither a plaintiff’s self-interested testimony nor equivocal health care provider testimony can touch.
Expert insights. Personalized for you.
52 
Let's personalize your content